Healthcare -
Biotechnology - NYSE - US
$ 2.51
-1.18 %
$ 845 M
Market Cap
-1.15
P/E
Price Target
Average
178.88%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
26.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Nuvation Bio Inc.
Wall Street analysts predict an average 1-year price target for NUVB of $7 , with forecasts ranging from
a
low of
$5 to a high of $10 .
NUVB Lowest Price Target
Wall Street Target
5 USD
99.20%
NUVB Average Price Target
Wall Street Target
7 USD
178.88%
NUVB Highest Price Target
Wall Street Target
10 USD
298.41%
REVENUE FORECAST
Revenue Forecast Chart NUVB
EBIT FORECAST
EBIT Forecast Chart NUVB
NET INCOME FORECAST
Net Income Chart NUVB